FarmavitaR+

Key trends and events in the 7 major markets

The generics market is growing, driven by rising healthcare costs and fed by a steady stream of patent expiries. Levels of generic uptake vary widely across the 7 major markets, with important implications for industry strategy.

The intensely competitive environment of the generics market is behind the wave of consolidations that has resulted in a reshuffle of the top 10 generics companies globally.

Competitive pressures have forced some generics companies out of the more mature markets, while others have adopted novel strategies to survive.

Several of the less mature markets, particularly Japan, in which generic uptake has historically been slow, are poised for growth, and as such present an attractive prospect for international players.

Read more...